At-a-glance KPIs, key findings, and strategic positioning of India’s dextromethorphan trade — 2025-Q4
KEY TAKEAWAYDextromethorphan 2025-Q4 exports total $1.2M across 44 countries, with J B CHEMICALS AND PHARMACEUTICALS LTD commanding 15.9% market share.
TOTAL SHIPMENTS
151
2025-Q4
EXPORT VALUE
$1.2M
FOB USD
TOTAL QUANTITY
8.3M
units shipped
INDIAN SUPPLIERS
69
unique exporters
GLOBAL BUYERS
72
unique importers
DESTINATIONS
44
countries
MEDIAN UNIT PRICE
$0.569
per unit
TOP-5 SHARE
42.7%
of total USD
BRANDED SHARE
72.8%
110 shipments
DOSAGE FORMS
14
product types
6 KEY FINDINGS
1
J B CHEMICALS AND PHARMACEUTICALS LTD is India's #1 Dextromethorphan exporter with $183.2K (15.9% market share).→ §5, Indian Supplier Rankings
2
Dextromethorphan reached 44 countries, with Australia as the top destination ($215.5K).→ §4, Global Destination Map
3
Market concentration is low (HHI: 570) — top 10 suppliers control 61.4% of exports.→ §5, Indian Supplier Rankings
4
94.4% of buyers (68 of 72) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Syrup dominates (48.8%) across 14 dosage forms.→ §7, Price Benchmarks
6
41 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
See which buyers your competitors are shipping to, at what price, through which ports
Identify buyers that are single-sourced (poaching opportunities)
Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
Discover which Indian exporters supply this product and what they sell
Benchmark the price you are paying vs the market median by country and dosage
Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 J B CHEMICALS AND PHARMACEUTICALS LTD leads in volume — how do 30 exporters compare on price × volume?
How to read: Every bubble is one Indian dextromethorphan exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Dextromethorphan report covers
KEY TAKEAWAYEvery figure in this report is grounded in real commercial dextromethorphan trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian dextromethorphan suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Dextromethorphan India trade report
P
Product scope
Dextromethorphan
All variants merged — branded and generic formulations of dextromethorphan
T
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
S
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
G
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
C
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
R
Shipments analysed
151
Every commercial dextromethorphan trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY2025-Q4 followed a v-curve: Oct $375.8K, Nov $275.3K, Dec $499.2K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$375.8K
Oct USD
48 shipments
2
$275.3K
Nov USD
-26.8% MoM
3
$499.2K
Dec USD
+81.3% MoM
4
V-curve
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov dipped 26.8% in USD but shipment count kept steady.
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $376K, making it the middle month by value.
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: J B CHEMICALS AND PHARMACEUTICALS LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import dextromethorphan from India, how much they buy, and who supplies each market
KEY TAKEAWAYAustralia absorbs 18.7% of India’s 2025-Q4 dextromethorphan trade ($215.5K). Beyond the top 10 destinations, 41 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Africa has 19 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 41 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much dextromethorphan India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$376K
32.6% of trade
12 countries · 45 shipments
Europe
$50K
4.4% of trade
5 countries · 10 shipments
Americas
$216K
18.7% of trade
7 countries · 22 shipments
Africa
$294K
25.5% of trade
19 countries · 67 shipments
Oceania
$215K
18.7% of trade
1 countries · 7 shipments
Fig 4.1 Australia is the #1 corridor ($215K) — 30 flow arcs from India radiate across 5 continents.
How to read: The world map shows every country colored by how much Indian dextromethorphan it receives (light = low, dark = high). Orange arcs radiate from India to the top 30 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
#
Destination
Total USD
Ships
#1 Indian supplier
USD
#2 Indian supplier
USD
#3 Indian supplier
USD
1
Australia
$215K
7
J B CHEMICALS AND PHARMACEUTICALS LTD
$170K
GRACURE PHARMACEUTICALS LTD
$45K
—
—
2
United States
$177K
13
ELYSIUM PHARMACEUTICALS LTD
$107K
SOFTGEL HEALTHCARE PVT LTD
$34K
OCEAN HEALTHCARE PVT LTD
$20K
3
Nepal
$155K
13
GLENMARK PHARMACEUTICALS LTD
$68K
INDCHEMIE HEALTH SPECIALITIES PVT LTD
$63K
MULTANI PHARMACEUTICALS LTD
$13K
4
Kenya
$74K
6
IZEK HEALTHCARE PVT LTD
$69K
SAKAR HEALTHCARE LTD
$5K
—
—
5
United Arab Emirates
$64K
12
INNOVA CAPTAB LTD
$31K
UNIMAX LABORATORIES
$27K
LEDERDAY PHARMA
$4K
6
Tanzania
$58K
10
JMB PHARMACEUTICALS PVT LTD
$21K
J B CHEMICALS AND PHARMACEUTICALS LTD
$13K
SCOTT EDIL PHARMACIA LTD
$12K
7
Myanmar
$51K
2
BLUE CROSS LABORATORIES PVT LTD
$27K
BRAWN LABORATORIES LTD
$24K
—
—
8
Sierra Leone
$41K
3
FRANCO-INDIAN PHARMACEUTICALS PVT LTD
$25K
RONAK EXIM PVT LTD
$10K
MEDDIGO MEDICARE PVT LTD
$6K
9
Afghanistan
$40K
7
LABORATE PHARMACEUTICALS INDIA LTD
$11K
UNIMAX LABORATORIES
$10K
REGOSHIN HEALTHCARE PVT LTD
$9K
10
France
$40K
3
AJANTA PHARMA LTD
$38K
NIYA HEALTHCARE PVT LTD
$2K
TABLETS MEDOPHARM PVT LTD
$278
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 32.6% of USD — but Australia is the single largest market.
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
18.7%
#1 country share
Australia alone
59.6%
Top 5 share
5 of 44 countries
89.4%
Top 15 share
Long tail of 29 countries = 10.6%
HHI 952
Destination HHI
Competitive spread
44
Countries served
Global pharma reach from India
19
Africa countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
69 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAYJ B CHEMICALS AND PHARMACEUTICALS LTD ($183.2K, 15.9% share) and ELYSIUM PHARMACEUTICALS LTD ($107.0K) together control 25.2% of India’s 2025-Q4 dextromethorphan trade. The top 5 suppliers hold 42.7%. 69 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian dextromethorphan suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 J B CHEMICALS AND PHARMACEUTICALS LTD leads by $76K over ELYSIUM PHARMACEUTICALS LTD — top 20 Indian exporters ranked by trade value
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: INDCHEMIE HEALTH SPECIALITIES is #5 by value but #16 by volume.
Fig 5.2 SAKAR HEALTHCARE LTD also leads by shipment count (11) but ranking shifts for volume-heavy players
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: INDCHEMIE HEALTH SPECIALITIES moves from #16 by volume to #5 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 69 dextromethorphan suppliers split into strategic segments
KEY TAKEAWAY18 suppliers (25%) generate 78.6% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 J B CHEMICALS AND PHARMACEUTICALS LTD and ELYSIUM PHARMACEUTICALS LTD sit in the leaders zone — high volume AND high value.
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 78.6% of USD — classic concentration.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 3 destinations and up to 1 importers per destination.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 4 destinations and up to 1 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
72 importers across 44 countries — who is buying Indian dextromethorphan and how much
KEY TAKEAWAYThe demand side is dramatically more fragmented than supply: the top 25 importers together hold only 81.0% of total USD. 94% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian dextromethorphan. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 INOVA PHARMACEUTICALS(AUSTRALIA) PT is the #1 importer at $170K (14.8%) — top 25 by trade value
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian dextromethorphan prices vary by supplier, country and dosage form
KEY TAKEAWAYDextromethorphan prices span 146232× ($0.0023 → $333.10). The coefficient of variation is 7.26. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. SAKAR HEALTHCARE LTDSourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. J B CHEMICALSSourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. BRAWN LABORATORIES LTDSourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. INDCHEMIE HEALTH SPECIALITIESSourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAYExtreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
Date
Exporter
Country
Dosage
Qty
USD
$/unit
Why
Oct 2025
ELYSIUM PHARMACE…
United States
Capsule
275
$99K
$358.74
Specialty / small-batch
Nov 2025
ELYSIUM PHARMACE…
United States
Capsule
25
$8K
$333.10
Specialty / small-batch
Dec 2025
IZEK HEALTHCARE …
Kenya
Solution
1K
$50K
$34.70
Specialty / small-batch
Oct 2025
SOFTGEL HEALTHCA…
United States
Capsule
572
$14K
$25.27
Specialty / small-batch
Nov 2025
SOFTGEL HEALTHCA…
United States
Capsule
1K
$15K
$13.39
Specialty / small-batch
Nov 2025
SOFTGEL HEALTHCA…
United States
Capsule
381
$4K
$10.67
Specialty / small-batch
Dec 2025
TIWARI PHARMA PV…
United States
Capsule
1K
$10K
$8.46
Specialty / small-batch
Oct 2025
MEDMALL PHARMACY…
Seychelles
—
24
$156.58
$6.52
Specialty / small-batch
Dec 2025
HEXA HEALTH CARE…
Mauritius
Tablet
80
$451.71
$5.65
Specialty / small-batch
Nov 2025
HEXA HEALTH CARE…
Mauritius
Tablet
75
$392.22
$5.23
Specialty / small-batch
↓ TOP 10 LOWEST USD/UNIT
Date
Exporter
Country
Dosage
Qty
USD
$/unit
Why
Dec 2025
SANGEETA PHARMA
Angola
Syrup
20K
$38.61
$0.0019
Dec 2025
DEN MARK PHARMAC…
Somalia
Syrup
100
$0.228
$0.0023
Small sample / trial shipment
Dec 2025
VARDHMAN EXPORTS
Tanzania
Syrup
20K
$53.45
$0.0027
Dec 2025
DEN MARK PHARMAC…
Somalia
Other
100
$0.285
$0.0028
Small sample / trial shipment
Dec 2025
MARKSANS PHARMA …
United States
Tablet
18K
$59.41
$0.0034
Bulk generic tablet
Dec 2025
NARAYANA HRUDAYA…
Cayman Islands
Lozenge
60
$0.205
$0.0034
Small sample / trial shipment
Dec 2025
NARAYANA HRUDAYA…
Cayman Islands
Lozenge
540
$1.85
$0.0034
Small sample / trial shipment
Nov 2025
BRAWN LABORATORI…
Myanmar
Tablet
4.2M
$24K
$0.0057
Bulk generic tablet
Dec 2025
J B CHEMICALS AN…
Russia
Syrup
8K
$49.41
$0.0059
Nov 2025
OCEAN HEALTHCARE…
United States
Capsule
985K
$10K
$0.0097
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
Dosage form is the #1 price driver, not destination
Light cells = easy-entry markets for small suppliers
Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship dextromethorphan, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAYDextromethorphan leaves India through 20+ ports. The top 5 (NHAVA SHEVA SEA (JNPT), RAXAUL, AHMEDABAD ICD) handle 81.7% of total USD. SEA moves 43% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 NHAVA SHEVA SEA (JNPT) handles $486K — top 20 Indian origin ports by trade value.
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
Route
Mode
Transit time
Notes
NHAVA SHEVA SEA (JNPT) → US East Coast
Sea
22–28 days
Via Suez; 2–3 transshipments typical
NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria)
Sea
18–24 days
Direct liner service available
MUMBAI AIR (SAHAR) → New York JFK
Air
3–5 days
Direct cargo; cold-chain available
MUNDRA SEA → Rotterdam
Sea
20–26 days
Via Suez; Hamburg also served
HYDERABAD AIR → London Heathrow
Air
2–4 days
Pharma-grade cargo corridor
CHENNAI SEA → Chittagong (Bangladesh)
Sea
7–12 days
Short-sea route; high frequency
RAXAUL → Birgunj (Nepal)
Road
1–2 days
Land border crossing
NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya)
Sea
14–20 days
Direct or via Colombo hub
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAYSEA dominates at 43% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
SEA
$694K
60.3% of USD · 43.0% of ships
ICD
$286K
24.9% of USD · 24.5% of ships
ROAD
$155K
13.5% of USD · 8.6% of ships
AIR
$16K
1.3% of USD · 23.8% of ships
Fig 8.3 The dominant corridor is NHAVA SHEVA SEA (JNPT) → Sea → Oceania ($170K).
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAYDR Congo is the most concentrated destination (HHI 10000, 1 suppliers). Seychelles is the most competitive (HHI 2200).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 DR Congo (HHI 10,000) is the most concentrated — Seychelles (HHI 2,200) is the most competitive.
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 17 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
Buyer
Country
Sole supplier
USD
Ships
Risk
INOVA PHARMACEUTICAL…
Australia
J B CHEMICALS AN…
$170K
6
HIGH
HHH PHARMACEUTICALS
United States
ELYSIUM PHARMACE…
$99K
1
MEDIUM
CARE ENTERPRISES CO …
Kenya
IZEK HEALTHCARE …
$69K
4
MEDIUM
FARMANURA PVT LTD
Nepal
GLENMARK PHARMAC…
$68K
8
MEDIUM
BALMED PHARMA PVT LTD
Nepal
INDCHEMIE HEALTH…
$63K
1
MEDIUM
NOUMED PHARMACEUTICA…
Australia
GRACURE PHARMACE…
$45K
1
MEDIUM
SHAMS NOORI PHARMA T…
United Arab Emirates
UNIMAX LABORATOR…
$38K
4
MEDIUM
STE PRINCE PHARMA SARL
DR Congo
SAKAR HEALTHCARE…
$34K
10
MEDIUM
Conclusion: 68 buyers depend on exactly one Indian supplier, representing $986K in trade. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
Buyer
Country
Suppliers
USD
Dominant
Resilience
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
Country
Tier
Lead
Price
Risk
Entry approach
Australia
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
United States
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Nepal
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Kenya
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
United Arab Emirates
Tier 3 (emerging)
3–5 days (air)
$0.10–$1/unit
LOW
First-mover advantage
Tanzania
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Myanmar
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Sierra Leone
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Afghanistan
Tier 3 (emerging)
3–5 days (air)
$0.10–$1/unit
LOW
First-mover advantage
France
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
DR Congo
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Mauritius
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Guinea-Bissau
Tier 3 (emerging)
14–28 days (sea)
$0.01–$0.10/unit
LOW
First-mover advantage
Venezuela
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
Turkey
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 1 markets in the Growth Opportunity zone (competitive + growing). 9 in Fragile Dependency (concentrated + shrinking).
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Afghanistan are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAYQuick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
ID
Action
Timing
Impact
A1
Pitch top single-source buyer in Australia
This Q
HIGH
A2
Offer alternative to top multi-source buyer
This Q
HIGH
A3
Audit DR Congo lock-ins (HHI 10000)
This Q
MED
A5
Enter Australia (2 suppliers)
This Q
HIGH
A6
Enter Nepal (5 suppliers)
This Q
MED
A8
Build United States distribution
6–12m
HIGH
A9
Bundle injection/infusion catalog for premium markets
6–12m
MED
B
FOR BUYERS
ID
Action
Timing
Impact
A4
Monitor rising exporters (J B)
This Q
MED
A7
Register for Australia tenders
6–12m
HIGH
A10
Track quarterly HHI shifts across key destinations
This Q
LOW
A11
Map competitor buyer portfolios quarterly
This Q
MED
A12
Qualify second source for single-source buyers
This Q
MED
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
#
Country
Region
Suppliers
Q4 USD
Growth
Barrier
Why this is easy
1
Australia
Other
2
$215K
+174.8%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
2
Nepal
Asia
5
$155K
0%
LOW
Low competition (5 suppliers), accessible market
3
United Arab Emirates
Other
5
$64K
+57.7%
LOW
Growing 58% with only 5 competitors
4
Kenya
Africa
2
$74K
0%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
5
Mauritius
Africa
3
$23K
+205.7%
LOW
Growing 206% with only 3 competitors
6
Afghanistan
Asia
5
$40K
+55.6%
LOW
Growing 56% with only 5 competitors
7
Myanmar
Asia
2
$51K
0%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
8
Sierra Leone
Africa
3
$41K
-100%
LOW
Low competition (3 suppliers), accessible market
9
France
Other
3
$40K
-85%
LOW
Low competition (3 suppliers), accessible market
10
DR Congo
Africa
1
$28K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
11
Guinea-Bissau
Africa
1
$22K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
12
Venezuela
Other
2
$21K
-100%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
13
Turkey
Other
1
$21K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
14
Nigeria
Africa
2
$17K
-100%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
15
Sudan
Africa
2
$16K
-95.2%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
This report covers 151 2025-Q4 Dextromethorphan shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/dextromethorphan
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAYThis section contains every one of the 151 2025-Q4 dextromethorphan shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian dextromethorphan shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
151
across all regions
TOTAL USD
$1.15M
2025-Q4 FOB value
UNITS
8.3M
tablets, capsules, etc.
SUPPLIERS
69
Indian exporters
BUYERS
72
global importers
COUNTRIES
44
destinations
§10.2 Regional breakdown
Africa
$294K
25.5%
19 ctry · 67 ships
Asia
$376K
32.6%
12 ctry · 45 ships
Europe
$50K
4.4%
5 ctry · 10 ships
Americas
$216K
18.7%
7 ctry · 22 ships
Oceania
$215K
18.7%
1 ctry · 7 ships
§10.3 Key insights from the data
🌍
Africa is the largest region at $294K (25.5%), spanning 19 countries.
🏢
69 Indian suppliers shipped to 72 buyers across 44 countries — average shipment value $8K.
📄
Top 0 markets: .
🔍
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
All 70 global dextromethorphan importers — complete list ranked by USD
KEY TAKEAWAYThis directory lists every company that imported Indian dextromethorphan in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
#
Buyer
Country
Ships
USD
Primary supplier
Dosage forms
1
INOVA PHARMACEUTICALS(AUSTRALIA) PT
Australia
6
$170K
J B CHEMICALS AND PH…
Solution, Syrup
2
HHH PHARMACEUTICALS
United States
1
$99K
ELYSIUM PHARMACEUTIC…
Capsule
3
CARE ENTERPRISES CO LTD
Kenya
4
$69K
IZEK HEALTHCARE PVT …
Solution
4
FARMANURA PVT LTD
Nepal
8
$68K
GLENMARK PHARMACEUTI…
Syrup
5
BALMED PHARMA PVT LTD
Nepal
1
$63K
INDCHEMIE HEALTH SPE…
Syrup
6
NOUMED PHARMACEUTICALS PTY LTD
Australia
1
$45K
GRACURE PHARMACEUTIC…
Syrup
7
PRODOSE INC
United States
4
$42K
SOFTGEL HEALTHCARE P…
Capsule
8
PLANET PHARMA SA
France
2
$39K
AJANTA PHARMA LTD
Gel, Eye Drops
9
SHAMS NOORI PHARMA TRADING CO
United Arab Emirates
4
$38K
UNIMAX LABORATORIES
Capsule
10
STE PRINCE PHARMA SARL
DR Congo
10
$34K
SAKAR HEALTHCARE LTD
Syrup
11
ASA YAKSHAN TRADING LLC
United Arab Emirates
6
$31K
INNOVA CAPTAB LTD
Suspension
12
SIN PHYU KYUN COMPANY LTD
Myanmar
1
$27K
BLUE CROSS LABORATOR…
Liquid
13
SAFARI CO LTD
Sierra Leone
1
$25K
FRANCO-INDIAN PHARMA…
Syrup
14
MEDCO PHARMA SARL
Guinea-Bissau
1
$22K
ARYA INFRACEUTICALS …
15
HYPERPHARM LTD
Mauritius
2
$21K
INDUS LIFE SCIENCES …
Syrup
16
MERPROJE LOJISTIK ULUSLARARASI TASI
Turkey
1
$21K
MARKSANS PHARMA LTD
Tablet
17
SHALINA HEALTHCARE NIGERIA LTDMUSHI
Nigeria
2
$17K
SHALINA LABORATORIES…
Lozenge
18
AMIPHARMA LABORATORIES LTD
Sudan
1
$16K
SAKAR HEALTHCARE LTD
Syrup
19
SUNSHINE HEALTHCARE LANKA LTDCO.REG
Sri Lanka
1
$16K
BLUE CROSS LABORATOR…
Liquid
20
RK PHARMACEUTICALS (TZ) LTD
Tanzania
2
$13K
J B CHEMICALS AND PH…
Lozenge
21
DIPALI PHARMACEUTICALS
Nepal
2
$13K
MULTANI PHARMACEUTIC…
Syrup
22
TO THE DIRECTORTANZANIA TANZANIATAN
Tanzania
1
$12K
SCOTT EDIL PHARMACIA…
Syrup
23
FATIMA HEALTHCARE LTD
Tanzania
1
$10K
JMB PHARMACEUTICALS …
Syrup
24
CABINET HEALTH INC
United States
1
$10K
OCEAN HEALTHCARE PVT…
Capsule
25
PHARMADOX HEALTHCARE LTDKW
Malta
1
$10K
ZENTIVA PVT LTD
Syrup
26
ZEYTAA LLC
United States
1
$10K
TIWARI PHARMA PVT LTD
Capsule
27
QUALITY HEALTHCARE COMPANY (SL) LTD
Sierra Leone
1
$10K
RONAK EXIM PVT LTD
Pack
28
SAMJAN GROUP INC
United States
1
$10K
OCEAN HEALTHCARE PVT…
Capsule
29
BIOGLASS PHARMACEUTICAL CASA DEREPR
Venezuela
1
$10K
ALDE MEDI IMPEX LTD
Solution
30
DELPHA PHARMA LTD
Afghanistan
1
$9K
REGOSHIN HEALTHCARE …
Syrup
31
PARTH PHARMA DISTRIBUTORS PVT LTD
Nepal
1
$8K
ALKEM LABORATORIES LTD
Drops
32
BAYBOON COMPANY FOR MEDICINES &
Iraq
1
$8K
KWALITY PHARMACEUTIC…
Solution
33
STATE TRADING ORGANIZATION PLC
Maldives
1
$7K
MEDLEY PHARMACEUTICA…
Syrup
34
HEALTH WELL PHARMARCY (SL) LTD
Sierra Leone
1
$6K
MEDDIGO MEDICARE PVT…
Tablet
35
COSPHARM INV
Namibia
2
$6K
FDC LTD
Syrup
36
GULF IMPEX FZC
Afghanistan
2
$6K
MEDMATRIX ASSOCIATES
Tablet
37
AIRLIE PHARMA
United States
3
$5K
KJD PHARMA PVT LTD
Solution
38
PHARMAVET LTD
Malawi
1
$4K
LEBEN LABORATORIES P…
Syrup
39
TRINPHARM CO LTD
Trinidad and Tobago
2
$4K
AUROCHEM LABORATORIE…
Syrup
40
ARIA PHRAMA CO LTD
Afghanistan
1
$4K
ANVIS LABORATORIES P…
Syrup
41
TRADE WINDS INTERNATIONAL FZ - LLCC
United Arab Emirates
1
$4K
LEDERDAY PHARMA
Syrup
42
ADK PHARMACEUTICAL COMPANY (PVT) LT
Maldives
1
$4K
MEDLEY PHARMACEUTICA…
Syrup
43
ROSHANE PHARMA SARL
Tanzania
1
$3K
KIAANZ BIOTECH
Syrup
44
DUSTI PHARMA LLC
Tajikistan
1
$3K
SPEY MEDICAL PVT LTD
Capsule
45
SOFIBANQUE SA
Tanzania
1
$3K
KESHAVLAL VAJECHAND
Syrup
46
AMIN PHARMACEUTICAL LIBERIA INCMR
Liberia
1
$2K
RONAK EXIM PVT LTD
Syrup
47
UNIQUE TRADE LINK PVT LTD
Nepal
1
$2K
MAPRA LABORATORIES P…
Dry Syrup
48
THE HEALINGS PLACE NATURAL HERBS
United Arab Emirates
1
$2K
WORLDWIDE AYURHUB PV…
Capsule
49
PPS INTERNATIONAL CO LTD
Cambodia
1
$2K
BLUE CROSS LABORATOR…
Liquid
50
AKRON PHARMA INC
United States
1
$1K
KJD PHARMA PVT LTD
Syrup
51
REGENCY EXIM TRADE LTD
Mauritius
4
$1K
HEXA HEALTH CARE PVT…
Tablet
52
MADHOL FIELD HOSPITAL
Sudan
1
$741.49
AKASH PHARMA EXPORTS
Solution
53
SONIA PHARMACY
Equatorial Guinea
1
$602.19
SONIA LABORATORY PVT…
Syrup
54
AMDJERAS FIELD HOSPITAL
Chad
2
$510.68
AKASH PHARMA EXPORTS
Tablet, Syrup
55
MARVIN PHARMA LTD
Burundi
1
$282.24
LEBEN LABORATORIES P…
Syrup
56
PLPN
France
1
$278.30
TABLETS MEDOPHARM PV…
Syrup
57
MINISTRY OF HEALTH & SOCIAL WELFARE
Liberia
1
$197.71
BIO PHARMA PRIMO IMPEX
58
ZAPATERO INTERNATIONAL LTD
Mauritius
1
$166.84
PLEASANT EXPORTS
Tablet
59
CAREWELL PHARMACY (PTY)LTD
Seychelles
2
$160.47
CHEMSELECT PVT LTD
Capsule, Syrup
60
PRISM INTERNATIONAL LLC
Seychelles
1
$156.58
MEDMALL PHARMACY PVT…
61
GOOD HEALTH (PTY) LTD
Seychelles
1
$96.42
JYOTI IMPEX
62
TIME-CAP LABS INC
United States
1
$59.41
MARKSANS PHARMA LTD
Tablet
63
SAFINA PHARMACEUTICALS LTD
Tanzania
1
$53.45
VARDHMAN EXPORTS
Syrup
64
JTNL LLC
Russia
1
$49.41
J B CHEMICALS AND PH…
Syrup
65
GENEX SU LDA
Angola
1
$38.61
SANGEETA PHARMA
Syrup
66
SAFARI PHARMACY INC
Liberia
1
$27.66
FRANCO-INDIAN PHARMA…
Syrup
67
TOMASZ LOSZKO
Poland
1
$9.18
NBG CORP
Tablet
68
EMIRATES POST COMPANY
United Arab Emirates
1
$2.90
DERRIC WOOD
69
HEALTH CITY CAYMAN ISLANDS (HCCI)
Cayman Islands
2
$2.05
NARAYANA HRUDAYALAYA…
Lozenge
70
GREENLIFE PHARMACEUTICALS LTD
Nigeria
1
$0.0000
FRANCO-INDIAN PHARMA…
Syrup
This report covers 151 2025-Q4 Dextromethorphan shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/dextromethorphan
Talk to our trade analyst
Need a custom dextromethorphan report or a deeper dive into any market? Our team is ready.